PixCell Medical, an innovator of speedy point-of-care diagnostic options, introduced right this moment that Soulbrain Holdings has acquired all of PixCell’s controlling shares, along with investing within the firm, making Soulbrain the bulk shareholder of PixCell Medical.
The acquisition of PixCell aligns with Soulbrain’s latest strategic transition into the healthcare and in vitro diagnostic house.
Soulbrain, a semiconductor specialist, just lately selected the bio-healthcare business as a progress engine and has already made a number of acquisitions and investments. The corporate recognized PixCell as a very good match for its technique to enter the diagnostic testing and point-of-care house, for the aim of distributing specialised diagnostic reagents and miniaturized medical gadgets.
Dr Nam Huh, Head of Biohealth Division and Vice President of Soulbrain, mentioned: “We recognized PixCell Medical as an organization that has confirmed to have disruptive know-how within the healthcare subject and we’re proud to have them be a part of the Soulbrain household. Our focus is to attempt to amass applied sciences that function the inspiration for the longer term improvement of the business, and we’ve diversified our enterprise portfolio to incorporate the distribution of specialised diagnostic reagents and miniaturized medical gadgets targeted on the purpose of care. Delivering better added worth and satisfaction to our clients is our high precedence, and PixCell is a superb addition to our rising household of aggressive life sciences affiliate corporations. “
PixCell Medical’s flagship product, HemoScreen, is a point-of-care blood testing platform that may carry out blood cell evaluation in 5 minutes by making use of novel laboratory and microfluidic know-how in an AI-powered cartridge. FDA cleared, CE marked, and TGA accepted, the HemoScreen performs five-part differential full blood depend (CBC) checks, producing outcomes equal to laboratory analyzers in a lot much less time. By making use of a novel proprietary microfluidic technique known as Viscoelastic Focusing to carry out cell evaluation, PixCell has miniaturized historically giant and complicated equipment.
Dr. Avishay Bransky, co-founder and CEO of PixCell Medical, mentioned: “This settlement is essential to the worldwide enlargement and commercialization of PixCell by HemoScreen. We consider Soulbrain shall be a superb strategic companion to assist us speed up our progress whereas persevering with to supply accessible and correct hematology check outcomes on a worldwide scale. Our objective is to supply dependable, easy and reasonably priced diagnostic data to those that want it, whether or not they’re sufferers with continual illnesses or individuals residing in distant areas with out entry to healthcare. The partnership with Soulbrain is a crucial milestone for us in reaching that objective. “